← FDA Drug Approvals (Drugs@FDA)

MICAFUNGIN IN SODIUM CHLORIDE 0.9%

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-09-29

Drug application

FDA Application #

NDA216142

Application type

New Drug Application

Brand name

MICAFUNGIN IN SODIUM CHLORIDE 0.9%

Generic name

MICAFUNGIN IN SODIUM CHLORIDE

Active ingredients

MICAFUNGIN SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2023-09-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown